Press Releases
Illumina and Deerfield Management partner to accelerate drug development
SAN DIEGO Illumina, Inc., a global leader in DNA sequencing and array-based technologies, and Deerfield Management, a healthcare investment management firm, announced a five-year partnership to apply a genetic-led approach to the discovery and development of novel therapies for...
Press Releases
Lonza and ALSA Ventures Collaborate to Provide Development and Manufacturing Services for Biotech Firms
Lonza and ALSA Ventures Colloboration: ALSA Ventures, a London based European biotech investment firm, and Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, announced today a framework collaboration agreement to help ALSA’s portfolio...
Press Releases
Torrent Pharma acquires 4 Brands from Dr.Reddy’s laboratories
Ahmedabad based Torrent Pharmaceuticals announced that it has entered into an agreement with Dr. Reddy's Laboratories Ltd. to acquire four of its brands "Styptovit-E", "Finast", "Finast-T", and "Dynapress".
Styptovit-E, a gynaecology product with an estimated market size of ~Rs. 500...
Press Releases
Scipio bioscience Announces Its Revolutionary Asteria Single-cell RNA-seq Kit and Companion Cytonaut Analysis Software Are Now Commercially Available
Life Science Newswire – Asteria©, the latest breakthrough single-cell RNA-sequencing kit developed by Scipio bioscience, is now commercially available for any researcher worldwide. This innovative hydrogel-based benchtop kit enables the transcriptomic profiling of 10,000 individual cells per sample, instrument-free....
Press Releases
Paradigm4 Launches Reveal: Proteomics to Transform the Search for Protein Isoform Biomarkers
Paradigm4 has unveiled REVEALTM: Proteomics, the newest use case specific app powered by the Paradigm4 FLASHTM high-performance bioinformatics platform.
REVEAL: Proteomics unlocks the power of advanced mass spec proteomics by simplifying cross sample and cross study searching for protein isoforms...
Press Releases
CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development
CYTENA, a BICO group company and a leading provider of high-precision instruments for handling biological cells, has entered a collaboration agreement with ExcellGene SA, a leading biologics CDMO that manufactures recombinant proteins. Together, the companies will streamline cell line...
Clinical Trials
Phesi global analysis of 2.5 million patients finds participants in breast cancer clinical trials are getting younger
New analysis from Phesi Inc., a data-driven provider of AI-powered clinical development analytics products and solutions, has found that since 2014 the number of women younger than 60 years of age participating in breast cancer clinical trials has increased...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















